Page last updated: 2024-08-25

triheptanoin and Metabolic Diseases

triheptanoin has been researched along with Metabolic Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Tucci, S; Wehbe, Z	1
De Lonlay, P; Douillard, C; Guffon, N; Mochel, F; Schiff, M; Vianey-Saban, C	1

Reviews

1 review(s) available for triheptanoin and Metabolic Diseases

Article	Year
Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases. Journal of inherited metabolic disease, 2020, Volume: 43, Issue:3 Topics: Animals; Fatty Acids; Glucose; Humans; Metabolic Diseases; Neurodegenerative Diseases; Oxidation-Reduction; Triglycerides	2020

Other Studies

1 other study(ies) available for triheptanoin and Metabolic Diseases

Article	Year
Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months. Molecular genetics and metabolism, 2021, Volume: 132, Issue:4 Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Adult; Carnitine; Child; Child, Preschool; Female; Humans; Infant; Male; Metabolic Diseases; Oxidation-Reduction; Quality of Life; Retrospective Studies; Treatment Outcome; Triglycerides; Young Adult	2021

Article

Year

Clinical outcomes in a series of 18 patients with long chain fatty acids oxidation disorders treated with triheptanoin for a median duration of 22 months.

Molecular genetics and metabolism, 2021, Volume: 132, Issue:4

Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adolescent; Adult; Carnitine; Child; Child, Preschool; Female; Humans; Infant; Male; Metabolic Diseases; Oxidation-Reduction; Quality of Life; Retrospective Studies; Treatment Outcome; Triglycerides; Young Adult

2021